Xu QQ - Search Results

1

Risk factors for arrhythmias occurred in cancer patients after chemotherapy: An evidence-based systematic review and meta-analysis.

Xu QQ, Han SJ, Wei XH, You LZ, Sun LC, Shang HC. Xu QQ, et al. Heliyon. 2024 Jul 6;10(14):e34176. doi: 10.1016/j.heliyon.2024.e34176. eCollection 2024 Jul 30. Heliyon. 2024. PMID: 39104480 Free PMC article.

2

HER2 amplification level is not a prognostic factor for HER2-positive breast cancer with trastuzumab-based adjuvant treatment: a systematic review and meta-analysis.

Xu QQ, Pan B, Wang CJ, Zhou YD, Mao F, Lin Y, Guan JH, Shen SJ, Zhang XH, Xu YL, Zhong Y, Wang XJ, Zhang YN, Sun Q. Xu QQ, et al. Among authors: xu yl. Oncotarget. 2016 Sep 27;7(39):63571-63582. doi: 10.18632/oncotarget.11541. Oncotarget. 2016. PMID: 27566580 Free PMC article. Review.

3

Prognostic Value of PD-L1 in Breast Cancer: A Meta-Analysis.

Wang C, Zhu H, Zhou Y, Mao F, Lin Y, Pan B, Zhang X, Xu Q, Huang X, Sun Q. Wang C, et al. Breast J. 2017 Jul;23(4):436-443. doi: 10.1111/tbj.12753. Epub 2017 Jan 12. Breast J. 2017. PMID: 28079291

4

Diagnostic Accuracy of PIK3CA Mutation Detection by Circulating Free DNA in Breast Cancer: A Meta-Analysis of Diagnostic Test Accuracy.

Zhou Y, Wang C, Zhu H, Lin Y, Pan B, Zhang X, Huang X, Xu Q, Xu Y, Sun Q. Zhou Y, et al. PLoS One. 2016 Jun 23;11(6):e0158143. doi: 10.1371/journal.pone.0158143. eCollection 2016. PLoS One. 2016. PMID: 27336598 Free PMC article.

5

Prognostic value of androgen receptor in triple negative breast cancer: A meta-analysis.

Wang C, Pan B, Zhu H, Zhou Y, Mao F, Lin Y, Xu Q, Sun Q. Wang C, et al. Oncotarget. 2016 Jul 19;7(29):46482-46491. doi: 10.18632/oncotarget.10208. Oncotarget. 2016. PMID: 27374089 Free PMC article.

6

Clinicopathological characteristics and long-term prognosis of screening detected non-palpable breast cancer by ultrasound in hospital-based Chinese population (2001-2014).

Pan B, Yao R, Zhu QL, Wang CJ, You SS, Zhang J, Xu QQ, Cai F, Shi J, Zhou YD, Mao F, Lin Y, Guan JH, Shen SJ, Liang ZY, Jiang YX, Sun Q. Pan B, et al. Among authors: xu qq. Oncotarget. 2016 Nov 22;7(47):76840-76851. doi: 10.18632/oncotarget.12319. Oncotarget. 2016. PMID: 27689334 Free PMC article.

7

Tumor biology, clinicopathological characteristics and prognosis of screen detected T1 invasive non-palpable breast cancer in asymptomatic Chinese women (2001-2014).

Pan B, Yao R, Zhou YD, Zhu QL, Shi J, Xu QQ, Wang CJ, You SS, Mao F, Lin Y, Shen SJ, Liang ZY, Jiang YX, Sun Q. Pan B, et al. Among authors: xu qq. Oncotarget. 2017 Apr 18;8(16):26221-26230. doi: 10.18632/oncotarget.15431. Oncotarget. 2017. PMID: 28412736 Free PMC article.

8

Prevalence and prognosis of malignancy in THSD7A-associated membranous nephropathy: a systematic literature review and clinical case study.

Xu Q, Li J, Yang Y, Zhuo L, Gao H, Jiang S, Li W. Xu Q, et al. Ren Fail. 2024 Dec;46(1):2355353. doi: 10.1080/0886022X.2024.2355353. Epub 2024 May 24. Ren Fail. 2024. PMID: 38785304 Free PMC article.

9

PD1 protein expression in tumor infiltrated lymphocytes rather than PDL1 in tumor cells predicts survival in triple-negative breast cancer.

Ren X, Wu H, Lu J, Zhang Y, Luo Y, Xu Q, Shen S, Liang Z. Ren X, et al. Cancer Biol Ther. 2018 May 4;19(5):373-380. doi: 10.1080/15384047.2018.1423919. Epub 2018 Feb 16. Cancer Biol Ther. 2018. PMID: 29336717 Free PMC article.

10

Comparison of sentinel lymph node biopsy guided by blue dye with or without indocyanine green in early breast cancer.

Shen S, Xu Q, Zhou Y, Mao F, Guan J, Sun Q. Shen S, et al. J Surg Oncol. 2018 Jun;117(8):1841-1847. doi: 10.1002/jso.25058. Epub 2018 May 22. J Surg Oncol. 2018. PMID: 29790178

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

273 results

Search Page

Filters